LeonaBio (LONA) EV/Sales: History & Chart

LeonaBio, Inc.(LONA)

Biotechnology · Bothell, WA

$5.67+0.09 (+1.61%)

Delayed quote: Oct 6, 2026, 1:34 PM EDT

About LeonaBio, Inc.

LeonaBio, Inc. operates as a biopharmaceutical firm engaged in clinical-stage development. Its core mission revolves around crafting small molecule therapies aimed at revitalizing neurological function and arresting the advancement of neurodegenerative conditions. The company's active development portfolio encompasses ATH-1105, an experimental therapy for amyotrophic lateral sclerosis (ALS) that is currently undergoing Phase 1 clinical assessment. Similarly, ATH-1020 is also in Phase 1 trials, targeting various neurodegenerative disorders. Furthermore, LeonaBio has an array of earlier-stage compounds in preclinical research. The company, which was originally established as Athira Pharma, Inc., rebranded itself as LeonaBio, Inc. in January 2026. Founded in 2011, its corporate headquarters are situated in Bothell, Washington.

Bothell, WA

19 employees

leonabio.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Mark J. Litton

View full financials

NAME	MARKET CAP	EV/SALES RATIO	TTM	3Y	5Y
LeonaBio, Inc. (LONA)	$22.36M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.11M	0.24x	0.37x	0.25x	0.21x
Rein Therapeutics Inc. (RNTX)vs ›	$22.89M	N/A	N/A	N/A	N/A
TherapeuticsMD, Inc. (TXMD)vs ›	$23.26M	6.00x	7.13x	10.91x	8.82x
Modular Medical, Inc. (MODD)vs ›	$21.44M	N/A	N/A	N/A	N/A
Quantum BioPharma Ltd. (QNTM)vs ›	$21.05M	N/A	207.31x	4938.40x	4938.40x
Kyntra Bio, Inc. (KYNB)vs ›	$24.21M	N/A	1.44x	1.04x	4.23x
ABVC BioPharma, Inc. (ABVC)vs ›	$24.51M	N/A	8660.16x	2951.18x	1830.92x
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.54M	N/A	390.99x	224.70x	223.08x
Actuate Therapeutics Inc (ACTU)vs ›	$20.10M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EV/SALES RATIO

TTM

LeonaBio, Inc. (LONA)

$22.36M

N/A

Aytu BioPharma, Inc. (AYTU)vs ›

$22.11M

0.24x

0.37x

0.25x